title: Markers of high-risk cutaneous melanoma: is there a winning combination for individualized prognosis?
authors.forename: J Andrew
authors.initials: JA
authors.lastname: Carlson
authors.forename: Jeffrey
authors.initials: J
authors.lastname: Ross
authors.forename: Michael
authors.initials: M
authors.lastname: Murphy
mesh_terms: D014408:Biomarkers, Tumor / Q000032:analysis*; D018797:Cell Cycle Proteins / Q000032:analysis; D050760:Cyclin-Dependent Kinase Inhibitor p27 / Q000032:analysis; D006801:Humans; D008545:Melanoma / Q000737:chemistry / Q000175:diagnosis* / Q000473:pathology / Q000556:secondary; D011379:Prognosis; D018570:Risk Assessment; D012878:Skin Neoplasms / Q000737:chemistry / Q000175:diagnosis* / Q000473:pathology
chemical_list: D014408:Biomarkers, Tumor; D018797:Cell Cycle Proteins; D050760:Cyclin-Dependent Kinase Inhibitor p27